Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
Study Identifier
M11-733
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
18 - 65 Years
Protocol Summary
The purpose is to study the efficacy and safety of ABT-436 in Major Depressive Disorder.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 85593
Little Rock, Arkansas, United States, 72211
Status
Not applicable
Location
Site Reference ID/Investigator# 87228
Garden Grove, California, United States, 92845
Status
Not applicable
Location
Site Reference ID/Investigator# 87214
National City, California, United States, 91950
Status
Not applicable
Location
Site Reference ID/Investigator# 87220
Oakland, California, United States, 94612
Status
Not applicable
Location
Site Reference ID/Investigator# 87215
Bradenton, Florida, United States, 34201
Status
Not applicable
Location
Site Reference ID/Investigator# 87225
South Miami, Florida, United States, 33143
Status
Not applicable
Showing {first} - {last} of {total} Results